Annual report pursuant to Section 13 and 15(d)

Note 15 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.24.0.1
Note 15 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Depreciation and other $ 136 $ 249
Net operating loss carryforwards 52,448 48,829
Research and development tax credits 2,219 2,034
Accruals and reserves 311 356
Capitalized research and development costs 1,422 640
Deferred revenue 220 213
Stock compensation expense 1,493 1,670
Lease assets 178 236
Other 50 22
Lease liabilities (152) (208)
Prepaid expenses (56) (41)
Less: Valuation allowance (58,269) (54,000)
Net deferred tax asset (liability) $ 0 $ 0